John Cox Insider Trading $RGEN REPLIGEN CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John Cox.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John Cox. John Cox is Director in REPLIGEN CORP ($RGEN) and EVP Pharmaceutical Oper & Tech in BIOGEN INC. ($IDPH) and Chief Executive Officer in Bioverativ Inc. ($BIVV) and in Sigilon Therapeutics, Inc. ($SGTX) and Director in Sigilon Therapeutics, Inc. ($SGTX).

John Cox in REPLIGEN CORP

Trading Symbol: RGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Cox: Director
Holdings: 923 shares
Current Value: $26,989
Latest Transaction: Mar 26 2020
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of John Cox in REPLIGEN CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, IDPH, BIVV, RGEN, SGTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 26 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	96.72	1,858	179,706	923	2.8 K to 923 (-66.81 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	42.07	3,304	138,999	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	38.76	2,434	94,342	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	26.12	3,366	87,920	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	41.19	3,632	149,602	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	12.91	14,000	180,740	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	97.17	1,016	98,725	2,781	3.8 K to 2.8 K (-26.76 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	96.45	1,187	114,486	3,797	5 K to 3.8 K (-23.82 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	95.13	24,533	2,333,824	4,984	29.5 K to 5 K (-83.11 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	42.07	3,304	138,999	29,517	26.2 K to 29.5 K (+12.60 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	38.76	2,434	94,342	26,213	23.8 K to 26.2 K (+10.24 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	26.12	3,366	87,920	23,779	20.4 K to 23.8 K (+16.49 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	41.19	3,632	149,602	20,413	16.8 K to 20.4 K (+21.64 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	12.91	14,000	180,740	16,781	2.8 K to 16.8 K (+503.42 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	12.91	10,000	129,100	14,000
Mar 05 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	93.39	10,000	933,900	2,781	12.8 K to 2.8 K (-78.24 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	12.91	10,000	129,100	12,781	2.8 K to 12.8 K (+359.58 %)
Feb 26 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	92.76	4,355	403,970	2,781	7.1 K to 2.8 K (-61.03 %)
Feb 26 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	94.85	100	9,485	7,136	7.2 K to 7.1 K (-1.38 %)
May 17 2019	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	67.71	2,109	142,800	2,109
May 17 2019	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	923	0	7,236	6.3 K to 7.2 K (+14.62 %)
May 17 2018	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	42.07	3,304	138,999	3,304
May 17 2018	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	1,486	0	6,313	4.8 K to 6.3 K (+30.79 %)
May 22 2017	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	38.76	2,434	94,342	2,434
May 22 2017	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	1,206	0	4,827	3.6 K to 4.8 K (+33.31 %)
May 13 2016	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	26.12	3,366	87,920	3,366
May 13 2016	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	1,763	0	3,621	1.9 K to 3.6 K (+94.89 %)
May 26 2015	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	41.19	3,632	149,602	3,632
May 26 2015	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	1,858	0	1,858	0 to 1.9 K

Page: 1